Rapid cognitive improvement in Alzheimer's disease following perispinal etanercept administration

Journal of Neuroinflammation
Edward L Tobinick, Hyman Gross

Abstract

Substantial basic science and clinical evidence suggests that excess tumor necrosis factor-alpha (TNF-alpha) is centrally involved in the pathogenesis of Alzheimer's disease. In addition to its pro-inflammatory functions, TNF-alpha has recently been recognized to be a gliotransmitter that regulates synaptic function in neural networks. TNF-alpha has also recently been shown to mediate the disruption in synaptic memory mechanisms, which is caused by beta-amyloid and beta-amyloid oligomers. The efficacy of etanercept, a biologic antagonist of TNF-alpha, delivered by perispinal administration, for treatment of Alzheimer's disease over a period of six months has been previously reported in a pilot study. This report details rapid cognitive improvement, beginning within minutes, using this same anti-TNF treatment modality, in a patient with late-onset Alzheimer's disease. Rapid cognitive improvement following perispinal etanercept may be related to amelioration of the effects of excess TNF-alpha on synaptic mechanisms in Alzheimer's disease and provides a promising area for additional investigation and therapeutic intervention.

References

Nov 9, 1992·Neuroscience Letters·V TancrediF Eusebi
Aug 19, 1991·Neuroscience Letters·H FillitG Wolf-Klein
Apr 1, 1991·Brain : a Journal of Neurology·T Shallice, P W Burgess
Dec 1, 1990·Journal of Neuroimmunology·J C GoodmanR K Narayan
Oct 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·W S GriffinC Araoz
Jun 20, 2000·Neurobiology of Aging·H AkiyamaT Wyss-Coray
Dec 29, 2000·Nature Neuroscience·L F Abbott, S B Nelson
Jan 5, 2002·Neurobiology of Aging·R T PerryR C Go
Jan 5, 2002·Neurobiology of Aging·R E Mrak, W S Griffin
Mar 23, 2002·Science·Eric C BeattieRobert C Malenka
Oct 26, 2002·Science·Dennis J Selkoe
Dec 12, 2002·Journal of Neurovirology·Patrick L McGeer, Edith G McGeer
Aug 12, 2003·Brain Research Bulletin·Elisabeth TarkowskiKaj Blennow
Aug 23, 2003·Journal of Neurology, Neurosurgery, and Psychiatry·E TarkowskiK Blennow
Nov 5, 2003·Journal of Neuroimmunology·Fiona M RossAlexej Verkhratsky
Jan 22, 2004·Nature Reviews. Neuroscience·Gina G Turrigiano, Sacha B Nelson
Jul 20, 2004·Journal of Neurology, Neurosurgery, and Psychiatry·M SjögrenE Tarkowski
Jul 24, 2004·Current Drug Targets·Mathias CacquevelDenis Vivien
Jan 11, 2005·Neurobiology of Aging·Robert E Mrak, W Sue T Griffin
Mar 11, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Angela M FlodenColin K Combs
Mar 18, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Deanna L TaylorJennifer M Pocock
Mar 25, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·David StellwagenRobert C Malenka
Apr 9, 2005·Journal of the American Geriatrics Society·Ziad S NasreddineHoward Chertkow
Apr 13, 2005·Trends in Molecular Medicine·Frank M LaFerla, Salvatore Oddo
May 17, 2005·Human Mutation·Simon M LawsMatthias Riemenschneider
Jun 10, 2005·Experimental Physiology·Mark PickeringJohn J O'Connor
Jun 25, 2005·Current Alzheimer Research·David H Small
Dec 6, 2005·The European Journal of Neuroscience·Qinwen WangRoger Anwyl
Jan 13, 2006·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Hantamalala Ralay RanaivoD Martin Watterson
Jan 21, 2006·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·William MêmeChristian Giaume
Feb 24, 2006·Proceedings of the National Academy of Sciences of the United States of America·Eric H ChangPatricio T Huerta
Mar 7, 2006·Mechanisms of Ageing and Development·Domenico LioCalogero Caruso
Mar 21, 2006·Nature·David Stellwagen, Robert C Malenka
Mar 30, 2006·Neurobiology of Aging·Antón AlvarezManuel Aleixandre
Jun 1, 2006·Journal of Neural Transmission·M M Edwards, S R Robinson
Aug 5, 2006·European Journal of Pharmacology·Karen F S Bell, A Claudio Cuello
Jan 4, 2007·The American Journal of Pathology·Anna CsiszarZoltan Ungvari
Jan 9, 2007·Trends in Molecular Medicine·Michael M HalassaPhilip G Haydon

❮ Previous
Next ❯

Citations

Jul 21, 2010·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Michael G Chez, Natalie Guido-Estrada
Dec 24, 2009·The British Journal of Nutrition·Robert KrikorianJames A Joseph
Oct 1, 2009·PPAR Research·Sriram RamananMike E Robbins
Mar 29, 2012·Current Gerontology and Geriatrics Research·Donna M Wilcock
May 1, 2011·Therapeutic Advances in Chronic Disease·Arthur A SimenLisa C Barry
Jan 12, 2008·Journal of Neuroinflammation·W Sue T Griffin
Aug 15, 2008·Immunity & Ageing : I & a·Marco RacchiGiovanni Scapagnini
Oct 31, 2008·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Adam R FergusonMichael S Beattie
Sep 4, 2008·Journal of Periodontology·Joseph Rogers
May 27, 2010·Vojnosanitetski pregled. Military-medical and pharmaceutical review·Dragan M PavlovićSanja Totić
Sep 11, 2009·Indian Journal of Psychiatry·Chittaranjan Andrade, Rajiv Radhakrishnan
Jun 24, 2014·Journal of Neuroinflammation·Victoria InghamClive Bate
Aug 12, 2014·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Marie Lou CamaraBernhard T Baune
Mar 7, 2014·Canadian Journal of Physiology and Pharmacology·Heba M MahdyAmani E Khalifa
Mar 22, 2014·Clinical Drug Investigation·Edward TobinickRobert N Spengler
Jul 8, 2014·Drug Discovery Today·Xin ChengRena Li
Sep 17, 2008·Journal of Clinical Psychopharmacology·Theoharis C Theoharides, Robert Doyle
Jan 27, 2011·The Journal of Nutrition, Health & Aging·Antoine PiauB Vellas
Jun 4, 2010·Expert Review of Neurotherapeutics·Edward Tobinick
Mar 18, 2009·Expert Opinion on Drug Delivery·Thomas M Barchet, Mansoor M Amiji
Jul 12, 2008·Expert Opinion on Investigational Drugs·Sabina A AntoniuRuxandra Ulmeanu
Sep 3, 2014·Journal of Neuroinflammation·David J Allison, David S Ditor
Dec 15, 2015·International Journal of Alzheimer's Disease·Mark E McCaulley, Kira A Grush
Apr 8, 2016·Translational Neurodegeneration·Cong ZhengJian-Zhi Wang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Genetics

Alzheimer's disease is a neurodegenerative disease. Discover genetic and epigenetic aspects of Alzheimer’s disease, including genetic markers and genomic structural variations with this feed.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Alzheimer's Disease: Neuroimaging

Neuroimaging can help identify pathological hallmarks of Alzheimer's disease (AD). Here is the latest research on neuroimaging modalities, including magnetic resonance imaging and positron emission tomography, in AD.

CSF & Lymphatic System

This feed focuses on Cerebral Spinal Fluid (CSF) and the lymphatic system. Discover the latest papers using imaging techniques to track CSF outflow into the lymphatic system in animal models.